ClinicalTrials.Veeva

Menu

Impact of Specialised Renal Care in Patients With Chronic Kidney Disease (IMPLICATE)

P

Patrick Saudan

Status

Completed

Conditions

Chronic Kidney Disease

Treatments

Behavioral: specialised renal care

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a prospective randomised trial studying patients with stage 3 to 5 chronic kidney disease (CKD) in order to determine the impact of specialised care by nephrologists compared to guidelines-directed management by primary care physicians (PCP) on: a) prognosis (clinical outcome), b) planning of renal replacement therapy (RRT) (urgent versus planned initiation RRT) and c) patient satisfaction.

Enrollment

242 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with CKD stage 3, 4 and 5 (CCl < 40 ml/min according to abbreviated MDRD formula) aged 18-80 years old and enrolled during a hospitalization.

Exclusion criteria

  • Patients previously known by nephrologists.
  • Estimated life expectancy < 1 year
  • Refusal or inability to sign writing consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

242 participants in 2 patient groups

nephrologists
Active Comparator group
Description:
Combined management PCP: nephrologists (at least 4 nephrology visits/year)
Treatment:
Behavioral: specialised renal care
Primary Care Physicians
Active Comparator group
Description:
Management by PCPs only, with the help of written instructions from our nephrology unit based on EBPG
Treatment:
Behavioral: specialised renal care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems